ERBB2 and cancer: EGCG also suppresses receptors or signaling proteins that are important for proliferation pathways in cancer cells, including the epidermal growth factor receptor (EGFR) [54], human epidermal growth factor receptor-2 (HER2) [55], insulin-like growth factor receptor (IGF) [56], and mitogen-activated protein kinase (MAPK) [57].